Literature DB >> 27363889

Practice and Educational Gaps in Radiation Therapy in Dermatology.

Armand B Cognetta1, Christopher M Wolfe2, David J Goldberg3, Hyokyoung Grace Hong4.   

Abstract

Guidelines for appropriate use of superficial radiation therapy are based on decades of research; although no formal appropriate use criteria have been developed, they are warranted. Superficial radiation in the outpatient dermatologic setting is the least expensive form of radiation treatment. Although higher cure rates may be possible with Mohs surgery, this should never argue against dermatologists retaining and refining a modality, nor should we limit its use by our successors. Most important, our elderly and infirm patients should continue to benefit from superficial radiation therapy in outpatient dermatologic settings.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appropriate use criteria; Basal cell carcinoma; Dermatologic radiotherapy; Nonmelanoma skin cancer; Squamous cell carcinoma; Superficial radiation treatment; Superficial radiotherapy; Treatment selection criteria

Mesh:

Year:  2016        PMID: 27363889     DOI: 10.1016/j.det.2016.02.011

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

1.  Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids.

Authors:  Mark S Nestor; Brian Berman; David Goldberg; Armand B Cognetta; Michael Gold; William Roth; Clay J Cockerell; Brad Glick
Journal:  J Clin Aesthet Dermatol       Date:  2019-02-01

Review 2.  Management of keratinocyte carcinoma - Special considerations in the elderly.

Authors:  Alison Bailey; Brooke Vasicek; Joy Tao; Monica Janeczek; Andia Mitri; Rebecca Tung
Journal:  Int J Womens Dermatol       Date:  2019-05-18

3.  Devices for dosimetric measurements and quality assurance of the Xstrahl 300 orthovoltage unit.

Authors:  Tze Yee Lim; Dragan Mirkovic; Xin Wang; Ramesh Tailor
Journal:  J Appl Clin Med Phys       Date:  2021-03-18       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.